Publications by Researcher: Peter, K

2015 Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators
Journal Of Experimental Medicine
Flierl, U Nero, TL Lim, B Arthur, JF Yao, Y Jung, SM Gitz, E Pollitt, AY Zaldivia, MTK Jandrot-Perrus, M Schafer, A Nieswandt, B Andrews, RK Parker, MW Gardiner, EE Peter, K
2017 Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
Nat. Commun.
Braig, D Nero, TL Koch, HG Kaiser, B Wang, XW Thiele, JR Morton, CJ Zeller, J Kiefer, J Potempa, LA Mellett, NA Miles, LA Du, XJ Meikle, PJ Huber-Lang, M Stark, GB Parker, MW Peter, K Eisenhardt, SU
2018 Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides: comment
J. Thromb. Haemost.
Flierl, U Nero, TL Lim, B Andrews, RK Parker, MW Gardiner, EE Peter, K
2018 CD39 and CD73 activity are protective in a mouse model of antiphospholipid antibody-induced miscarriages
J. Autoimmun.
Samudra, AN Dwyer, KM Selan, C Freddi, S Murray-Segal, L Nikpour, M Hickey, MJ Peter, K Robson, SC Sashindranath, M Cowan, PJ Nandurkar, HH
2019 Pharmacological inhibition of LIM kinase pathway impairs platelets functionality and facilitates thrombolysis
Experimental Cell Research
Antonipillai, J Rigby, S Bassler, N Peter, K Bernar, O
2021 A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction
Basic Research In Cardiology
Siegel, PM Bojti, I Bassler, N Holien, J Flierl, U Wang, XW Waggershauser, P Tonnar, X Vedecnik, C Lamprecht, C Stankova, I Li, T Helbing, T Wolf, D Anto-Michel, N Mitre, LS Ehrlich, J Orlean, L Bender, I Przewosnik, A Mauler, M Hollederer, L Moser, M Bode, C Parker, MW Peter, K Diehl, P